tert-butyl N-((4-hydroxypiperidin-4-yl)methyl)carbamate → HCID 70667976、化合物
反応式
[OH:1][C:2]1([CH2:8][NH:9][C:10](=[O:16])[O:11][C:12]([CH3:15])([CH3:14])[CH3:13])[CH2:7][CH2:6][NH:5][CH2:4][CH2:3]1.[N:17]1[CH:22]=[CH:21][CH:20]=[CH:19][C:18]=1[C:23]1[S:24][C:25]([CH:28]=O)=[CH:26][N:27]=1>>[OH:1][C:2]1([CH2:8][NH:9][C:10](=[O:16])[O:11][C:12]([CH3:13])([CH3:15])[CH3:14])[CH2:7][CH2:6][N:5]([CH2:28][C:25]2[S:24][C:23]([C:18]3[CH:19]=[CH:20][CH:21]=[CH:22][N:17]=3)=[N:27][CH:26]=2)[CH2:4][CH2:3]1参加物
3
実験手順
According to the same procedure described in Example 101, starting with the compound prepared in Example 251 instead of the compound prepared in Example 226 and the compound prepared in Example 139 instead of 2-phenylthiazole-5-carbaldehyde, the title compound having the following physical data was obtained.
出典と根拠
- ORDレコード
- ord-e195638167c14b2090a56ae0314b2b76
- 出典データセット
- uspto-grants-2014_08
- 特許番号
- US08809538B2